Option Care Posts $1.49B Q3 Revenue, Pulls Guidance Ahead of $32.05 Buyout
OPCH sits 77% above its 52-week low of $18.01.
Summary
Option Care reported Q3 2026 revenue of $1.4935 billion, up 4.1% year over year, with EPS of 38c and net income of $57.4 million. The company also withdrew its guidance. That follows the 8-K filed minutes earlier this morning and comes as the company sits inside a definitive agreement to be acquired by CD&R and McKesson for $32.05 per share in cash, a roughly $5.8 billion enterprise value. The numbers matter less than usual here: with the stock pinned near the $32.05 deal price, the print is a check on whether the business is holding up into the close rather than a driver of valuation. The pulled guidance is consistent with a company in a pending take-private. The definitive proxy filed October 28th set the special meeting for shareholders to vote on the merger — that vote is the event that actually matters for the stock.
At the time of this announcement, OPCH was trading at $31.79 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.8B. The 52-week trading range was $18.01 to $36.80. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.